naltrexone has been researched along with c-peptide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cobelli, C; De Palo, C; Federspil, G; Macor, C; Rossi, E; Ruggeri, A; Vettor, R | 1 |
Caruso, A; Ciampelli, M; Cucinelli, F; Fortini, A; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S | 1 |
Bianchi, A; De Luca, AM; De Marinis, L; Fulghesu, AM; Lanzone, A; Mancini, A; Mancuso, S; Valle, D; Villa, P | 1 |
Caruso, A; Ciampelli, M; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S; Murgia, F | 1 |
Calvillán, M; Castillo, T; López, G; Rabenbauer, B; Sir-Petermann, T; Wildt, L | 1 |
Barini, A; Cento, RM; Cucinelli, F; Lanzone, A; Mancuso, S; Perri, C; Soranna, L | 1 |
3 trial(s) available for naltrexone and c-peptide
Article | Year |
---|---|
Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
Topics: Adult; Body Mass Index; C-Peptide; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Naltrexone; Narcotic Antagonists; Obesity | 1997 |
Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Dehydroepiandrosterone Sulfate; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hyperandrogenism; Insulin; Insulin Secretion; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Naltrexone; Narcotic Antagonists; Opioid Peptides; Placebos; Testosterone | 1998 |
Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.
Topics: Blood Glucose; C-Peptide; Fasting; Female; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Postmenopause; Treatment Outcome | 2004 |
3 other study(ies) available for naltrexone and c-peptide
Article | Year |
---|---|
Effect of naltrexone treatment on insulin secretion, insulin action and postprandial thermogenesis in obesity.
Topics: Adult; Blood Glucose; Body Composition; Body Temperature Regulation; C-Peptide; Energy Metabolism; Female; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Models, Biological; Naltrexone; Obesity; Oxidation-Reduction | 1994 |
Effect of opioid blockade on insulin metabolism in polycystic ovarian disease.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; C-Peptide; Female; Glucose Tolerance Test; Humans; Insulin; Naltrexone; Narcotic Antagonists; Polycystic Ovary Syndrome | 1995 |
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.
Topics: Adolescent; Adult; C-Peptide; Female; Glucose; Humans; Hyperinsulinism; Insulin Resistance; Naltrexone; Opioid Peptides; Polycystic Ovary Syndrome | 1998 |